GlassScriptPhysician profile
Lorelli Sitahal
NPI 1598788937
$2,433.70
in general payments reported to CMS, 2019-2025
8 companies · $59.30 in 2025
The $59.30 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $788 · 2020: $824 · 2021: $233 · 2022: $459 · 2023: $49.69 · 2024: $19.93 · 2025: $59.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $128.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $819.01 | 2019-2023 | |
| Janssen Products, LP | $704.77 | 2019-2022 | |
| Janssen Biotech, INC. | $538.15 | 2019-2020 | |
| Viiv Healthcare Company | $146.03 | 2020 | |
| Theratechnologies INC. | $137.72 | 2019-2025 | Trogarzo, Egrifta |
| Abbvie INC. | $50.20 | 2020-2021 | |
| Exact Sciences Corporation | $19.93 | 2024 | Cologuard Collection Kit |
| Madrigal Pharmaceuticals | $17.89 | 2025 | Rezdiffra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorelli Sitahal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.